Skip to content
healthcare.dev

Rilpivirine

NDC 70069-848, Rilpivirine, tablet, film coated, from Somerset Therapeutics, LLC.

Product NDC
70069-848
Status
Listed
Labeler
Somerset Therapeutics, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218798
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70069-848 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RILPIVIRINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
70069-848-307006908483030 TABLET, FILM COATED in 1 BOTTLE (70069-848-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fb109de9-d88d-4405-8dd6-d458cbc387d1

Use it

Look up 70069-848 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70069-848 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70069-848. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.